Feedback / Questions
Alzumab (itolizumab) - Biocon, Equillium, Ono Pharma
https://www.businesswire.com/news/home/20250206241338/en/Equillium-Announces-Positive-Data-from-Phase-2-Study-Evaluating-Itolizumab-in-Patients-with-Moderate-to-Severe-Ulcerative-Colitis
Feb 6, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next